Fdc Limited (FDC)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
285.5
0.1(0.04%)

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl-LBW, Simyl-MCT, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. The company was founded in 1936 and is headquartered in Mumbai, India.

Pricing Updates

TODAY'S HIGH

288.9

TODAY'S LOW

283.8

52 WEEK HIGH

322.9

52 WEEK LOW

225

Major Holders

% of Shares Held by
All Insider

69.68%

% of Shares Held by
Institutions

10.17%

% of Float Held by
Institutions

33.54%

Number of Institutions
Holding Shares

24

Company Overview

MARKET CAP

4736.73 Cr.

ETERPRISE VALUE

4353.02 Cr.

NO. OF SHARES

16.59 Cr.

BOOK VALUE

113.654

DIV. YIELD

0.8%

DEBT

32.41 Cr.

GROSS PROFIT

970.24 Cr.

CASH

420.63 Cr.

REVENUE

1622.48 Cr.

REVENUE/SHARE

96.727

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-43.35 Cr.-27.78 Cr.-135.73 Cr.-94.12 Cr.
Change To Liabilities67.61 Cr.-45.65 Cr.51.73 Cr.-26.96 Cr.
Total cashflows from Investing Activities-144.56 Cr.-77.15 Cr.-98.35 Cr.-120.32 Cr.
Net Borrowings-8.67 Cr.-9.81 Cr.-6.09 Cr.-9.03 Lakhs
Total Cash from Financing Activities-9.83 Cr.-129.34 Cr.-141.99 Cr.-6.64 Lakhs
Other Liabilities-24.61 Cr.-1.20 Cr.11.71 Cr.-3.89 Cr.
Total Assets0000
Net Income216.40 Cr.301.34 Cr.239.87 Cr.169.78 Cr.
Change in Cash7.29 Cr.55.46 Lakhs9.96 Cr.-8.21 Cr.
Effect of Exchange Rate4.51 Lakhs-2.43 Lakhs-7.06 Lakhs-25 Lakhs
Total Cash from Operating Activities161.65 Cr.207.08 Cr.250.38 Cr.112.42 Cr.
Depreciation37.30 Cr.35.99 Cr.35.69 Cr.31.54 Cr.
Other Cashflows from Investing Activities25.82 Cr.9.43 Cr.41.10 Cr.16 Cr.
Dividends Paid00-13.67 Cr.-13.67 Cr.
Change to Inventory-89.77 Cr.-4.96 Cr.-36.17 Cr.-13.30 Cr.
Change to Account Receivables25.04 Cr.12.40 Cr.-35.04 Cr.-6.89 Cr.
Other Cashflows from Financing Activities-1.16 Cr.-22.19 Cr.-2.17 Cr.2.39 Lakhs
Change to Net Income-70.33 Cr.-92.65 Cr.-19.18 Cr.-39.54 Cr.
Capital Expenditures-132.54 Cr.-62.53 Cr.-31.23 Cr.-42.72 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax289.39 Cr.387.72 Cr.319.95 Cr.236.63 Cr.
Minority Interest-42.84 Lakhs-17.32 Lakhs-17.32 Lakhs-17.32 Lakhs
Net Income216.38 Cr.296.24 Cr.267.26 Cr.197.77 Cr.
Selling General Administrative343.33 Cr.335.25 Cr.334.36 Cr.277.24 Cr.
Gross Profit997.70 Cr.896.22 Cr.897.28 Cr.721.01 Cr.
Ebit216.38 Cr.296.24 Cr.267.26 Cr.197.77 Cr.
Operating Income216.38 Cr.296.24 Cr.267.26 Cr.197.77 Cr.
Other Operating Expenses400.68 Cr.226.91 Cr.258.26 Cr.212.82 Cr.
Interest Expense-3.08 Cr.-2.76 Cr.-3.01 Cr.-1.08 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense73.22 Cr.86.52 Cr.80.07 Cr.66.84 Cr.
Total Revenue1527.91 Cr.1333.20 Cr.1344.19 Cr.1090.69 Cr.
Total Operating Expenses1311.53 Cr.1036.95 Cr.1076.92 Cr.892.92 Cr.
Cost of Revenue530.21 Cr.436.97 Cr.446.90 Cr.369.68 Cr.
Total Other Income Expense Net73 Cr.91.48 Cr.52.68 Cr.38.86 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.216.16 Cr.301.19 Cr.239.87 Cr.169.78 Cr.
Net Income Applicable to Common Shares216.40 Cr.301.34 Cr.239.87 Cr.169.78 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets4.63 Cr.4.39 Cr.6.21 Cr.6.43 Cr.
Capital Surplus0000
Total Liabilities313.84 Cr.222.27 Cr.265.49 Cr.194.64 Cr.
Stock Holder Equity1956.79 Cr.1734.13 Cr.1547.42 Cr.1445.23 Cr.
Minority Interest-42.84 Lakhs-17.32 Lakhs00
Other Liabilities128.29 Cr.59.72 Cr.62.56 Cr.54.45 Cr.
Total Assets2270.20 Cr.1956.23 Cr.1812.92 Cr.1639.88 Cr.
Common Stock16.88 Cr.16.88 Cr.17.09 Cr.17.44 Cr.
Retained Earnings01711.46 Cr.1527.51 Cr.1424.81 Cr.
Other Liabilities16.40 Cr.11.26 Cr.9.53 Cr.15.10 Cr.
Good Will0000
Treasury Stock1939.90 Cr.5.78 Cr.2.81 Cr.2.97 Cr.
Other Assets75.40 Cr.48.76 Cr.26.13 Cr.26.21 Cr.
Cash38.65 Cr.30.43 Cr.29.87 Cr.19.91 Cr.
Current Liabilities272.15 Cr.203.99 Cr.246.33 Cr.179.05 Cr.
Long Term Asset Charges0000
Short Long Term Debt10 Lakhs13.57 Lakhs14.65 Lakhs11.44 Lakhs
Other Stockholder Equity1939.90 Cr.5.78 Cr.2.81 Cr.2.97 Cr.
Property Plant Equipment805.24 Cr.703.96 Cr.691.13 Cr.688.12 Cr.
Total Cur. Assets1000.18 Cr.933.74 Cr.927.13 Cr.739.99 Cr.
Long Term Investments384.72 Cr.265.35 Cr.162.31 Cr.179.10 Cr.
Net Tangible Assets1952.15 Cr.1729.74 Cr.1541.21 Cr.1438.79 Cr.
Short Term Investments500.76 Cr.000
Net Receivables82.72 Cr.118.19 Cr.144.31 Cr.93.48 Cr.
Long Term Debt65.15 Lakhs20.80 Lakhs34.36 Lakhs49.01 Lakhs
Inventory304.69 Cr.214.92 Cr.209.96 Cr.173.78 Cr.
Accounts Payable136.93 Cr.77.27 Cr.117.85 Cr.77.61 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account